Peran Therapeutics

Peran Therapeutics is a biotechnology company specializing in the development of next-generation non-viral gene therapies. The company utilizes its proprietary Protein-Shell-Particle (P-S-P) platform to deliver therapeutic payloads, such as mRNA and gene-editing tools, with high precision and reduced immunogenicity. By leveraging engineered protein nanocages, Peran aims to overcome the limitations of traditional lipid nanoparticle (LNP) and viral vector delivery systems. Their current pipeline focuses on addressing unmet needs in liver-directed genetic diseases and oncology. The company maintains a global presence with operations in both the United States and China to accelerate its research and development efforts.